All Type of News
What is the background for Kwang Dong Pharmaceutical and GSK to hold hands?Kwang Dong Pharmaceutical has attracted interests of the industry as it takes charge of domestic marketing of the GSK’s 8 vaccines for infants.
A question has been raised that ...
|
The distribution industry opposing to the unilateral distribution cost reduction of a multinational pharmaceutical company
As several multinational pharmaceutical companies have unilaterally decreased distribution cost, the pharmaceutical distribution industry has disgusted and opposed to it.
Currently, the pharmaceutical distribution in...
Bayer Healthcare completed taking over OTC drugs of MSD KoreaThe OTC drug department of Bayer Healthcare announced on the 3rd that it has completed taking over OTC drugs of MSD Korea, the Korean branch of Merk & Co., Inc. (hereinafter Mer...
|
Voluntary price reduction of generic products in the NSAID ‘celecoxib’ war
As the patent of the selective COX-2 inhibition anti-inflammatory drug ‘Celebrex(generic name: celecoxib)’ will be expired on the coming 11th of June, approximately 100 generics are expected to be poured out.
Since i...
The spread of ‘MERS’ warns infection management among hospitals
As Middle East Respiratory Syndrome patients are increased to 30 and the tertiary infection occurred for the first time in the world, medical institutions have put the best effort to prevent hospitals from the infecti...
The National Assembly pushes forward with the ‘MERS Compensation Act’
While the number of MERS-diagnosed and -suspected patients increases rapidly, the National Assembly has pushed forward with a bill to compensate damages caused by isolation and medical institutions.
Assemblyperson Yo...
Inevitable competition between multinational and domestic pharmaceutical companies in the KRW 400 billion NSAIDs market
In the KRW 400 billion NSAIDs (non-steroidal anti-inflammatory drugs) market, the ‘2nd’ severe competition is expected among domestic and multinational pharmaceutical companies. .
First and foremost, among domestic p...
Business departments of pharmaceutical companies concerning the spread of MERS “What should we do”
Even pharmaceutical companies dealing with drugs seem to be helpless against MERS.
In this circumstance where there has been no vaccine and treatment developed, medical sales representatives are defenselessly exposed...
The threat of the MERS spread creates confusion across the nation and busyness among pharmacies at the same time
Caused by the spread of MERS, confusion across the country has been reflected in pharmacies.
According to the pharmacy field on the 3rd, consumers visiting to pharmacies have become noticeably frequent right after th...
Will pharmaceutical companies manufacturing the allopathic treatment of MERS, ‘Ribavirin,’ be able to take the advantage?
While continuous death of MERS (Middle East Respiratory Syndrome) patients has suddenly increased interested in the treatment, the industry is paying attention to the manufacturing pharmaceutical companies of Ribaviri...
